Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry

Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry

Background. There is no consensus on rabbit antithymocyte globulin (rATG) dose used for induction immunosuppression in pediatric kidney transplants. We aimed to identify whether a lower rATG dose provides safe and effective immunosuppression compared with a higher dose. Methods. We retrospectively a...

Full description

Bibliographic Details
Main Authors: Isa F. Ashoor, MD, Karen Martz, MS, Shirley Galbiati, MS, Robbie A. Beyl, PhD, Vikas R. Dharnidharka, MD, MPH, on behalf of the NAPRTCS Investigators
Format: Article
Language:English
Published: Wolters Kluwer 2020-09-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001042

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001042

Similar Items